Lori Ranallo
Nurse Practitioner · Westwood, KSNPI 1801964366
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Seagen Inc. accounts for 64.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $21,781 and has fallen 97.3% since, to $583 in 2025. Among nurse practitioner clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $326.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$31K
- Myriad Genetic Laboratories, Inc.$11K
- Pfizer$3K
- Fresenius Kabi USA, LLC$850
- AstraZeneca$734
- Puma Biotechnology, Inc.$125
- plus $682 from 9 others
What the payments were for
- Consulting fees$4,78810%
- Speaking & faculty fees$27,13856%
- Travel & lodging$12,29925%
- Food & beverage$3,8118%
- Education$2551%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 76 | $31,244 |
| Myriad Genetic Laboratories, Inc. | 45 | $11,265 |
| Pfizer | 5 | $3,390 |
| Fresenius Kabi USA, LLC | 1 | $850 |
| AstraZeneca | 7 | $734 |
| Puma Biotechnology, Inc. | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $121 |
| Merck | 4 | $118 |
| Daiichi Sankyo Inc. | 1 | $118 |
| Genentech USA, Inc. | 2 | $113 |
| Johnson & Johnson | 1 | $85 |
| Coherus Oncology, Inc. | 1 | $66 |
| Amgen | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TUKYSA$33,205
- myRisk$7,808
- BRACAnalysis$2,000
- myChoice CDx$375
- DATROWAY$233
- PreciseTumor$150
- Nerlynx$125
- Orserdu$121
- ADCETRIS$111
How this compares
$48,290 in reported general payments places this provider in the 95th percentile of 1,326 nurse practitioner providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 20 | $196 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Westwood
- Gary GrafTopeka$726K
- Anna ShortRoeland Park$215K
- Shannon GreggTopeka$140K
- Morteza RabiiOverland Park$88K
- Constance JacobWichita$65K
- Michelle KirkHutchinson$58K
- Catherine PowellWichita$50K
- Kristyn MilburnPleasanton$23K
- Kelli BradburyTopeka$20K
- Diane GonzalezOverland Park$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.